HOME >> BIOLOGY >> NEWS
Gene's activity points to more lethal subtype of AML

COLUMBUS , Ohio -- A new study shows that the activity of a particular gene can identify people who have a more lethal form of acute myeloid leukemia, singling out those patients who should receive more intense therapy.

The gene, called ERG (for ETS-related gene), has also been linked to chronic leukemia and to breast and prostate cancer.

The findings apply to acute myeloid leukemia (AML) patients with leukemia cells that have normal-looking chromosomes, a feature that occurs in about half of AML patients.

Among these patients, those with leukemia cells showing high ERG activity are almost six times more likely to relapse or die within five years than are patients with low ERG expression following standard therapy.

The Cancer and Leukemia Group B study was initiated by researchers at the Ohio State University Comprehensive Cancer Center, and their findings were published online in the Journal of Clinical Oncology.

Our study shows that high ERG activity predicts a poor prognosis in these patients, even when other molecular markers are taken into consideration, says first author Guido Marcucci, associate professor of internal medicine and an AML specialist at Ohio State's James Cancer Hospital and Solove Research Institute.

The findings mean that these patients require a stem-cell transplant or other aggressive therapy, and that patients with low ERG activity can be treated using standard therapy.

The research confirms a 2005 study led by the same Ohio State researchers in a completely independent set of patients, Marcucci says.

Both studies together further refine the molecular classification of AML in this group of patients and should help us improve treatment outcomes, says principal investigator Clara D. Bloomfield, professor of internal medicine, and an internationally recognized specialist in AML.

About 13,400 new cases of AML are expected this year, and a littl
'"/>

Contact: Darrell E. Ward
Darrell.Ward@osumc.edu
614-293-3737
Ohio State University
9-Jul-2007


Page: 1 2

Related biology news :

1. Genes discovery could help prevent a leading cause of blindness in the elderly
2. Genes mutations found to cause life-threatening aortic disease
3. Prenatal alcohol exposure alters brain activity in the frontal-striatal areas
4. Weizmann Institute scientists develop a general control switch for protein activity
5. Slow wave activity during sleep is lower in African-Americans than Caucasians
6. ChemGenex announces publication confirming activity of Ceflatonin in T315I-Positive CML
7. Neuronal activity gives clues to working memory
8. CSHL links activity in brain synapses and developmental abnormalities with schizophrenia gene
9. Hyperactivity and academic achievement could be linked by genetics
10. Food cue-related brain activity linked to obesity?
11. A relative of anti-aging gene Klotho also influences metabolic activity, obesity

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/4/2019)... ... , ... Lajollacooks4u is delighted to announce it has been named as one ... given only to businesses that have achieved consistently outstanding traveler reviews on TripAdvisor, as ... To qualify for the Certificate of Excellence –- an award that only 10 percent ...
(Date:5/31/2019)... ... May 30, 2019 , ... Researchers from Ambry Genetics ... significant differences in the prevalence of hereditary genetic mutations, also called germline mutations, ... women. Results will be presented at the 2019 American Society of Clinical Oncology ...
(Date:5/26/2019)... ... ... Zolgensma (Novartis, AveXis), an AAV-delivered gene therapy used to treat spinal muscular atrophy ... by the Food and Drug Administration today. , The treatment is now ... United States and the second-ever approved treatment for SMA. , FDA granted priority review ...
Breaking Biology News(10 mins):
(Date:6/18/2019)... ... ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell ... of a person’s own adipose-derived stem cells to treat their osteoarthritis. The first clinical ... IND is the first of several planned clinical trials which will enable qualified PSC-enrolled ...
(Date:6/11/2019)... ... June 11, 2019 , ... ... Clinic, a national leader in opioid treatment, announced today they are partnering to ... , Mytonomy recently deployed its virtual care platform at the Mayo Clinic to ...
(Date:5/31/2019)... City, California (PRWEB) , ... ... ... allowance of our patent applications from the USPTO providing proprietary interest to ... AND METHOD FOR SLEEP DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP rights ...
(Date:5/21/2019)... ABABA, Ethiopia (PRWEB) , ... May 21, 2019 ... ... für Brauerei in Berlin (VLB) today officially opened the inaugural Africa Brewing Conference ... brewing and malting industry in Africa. The event, which is supported through a ...
Breaking Biology Technology:
Cached News: